Why Therapeutic Trials Fail in Primary Tauopathies
Mov Disord
.
2023 Apr;38(4):545-550.
doi: 10.1002/mds.29322.
Epub 2023 Jan 20.
Authors
Nahid Olfati
1
,
Hamidreza Ghodsi
1
,
Ece Bayram
1
,
Irene Litvan
1
Affiliation
1
Parkinson and Other Movement Disorders Center, Department of Neurosciences, University of California San Diego, La Jolla, California, USA.
PMID:
36670054
PMCID:
PMC10398638
DOI:
10.1002/mds.29322
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Humans
Tauopathies*
tau Proteins
Substances
tau Proteins
Grants and funding
K99 AG073453/AG/NIA NIH HHS/United States
U01 NS100610/NS/NINDS NIH HHS/United States
R21 NS114764/NS/NINDS NIH HHS/United States
R01 AG038791/AG/NIA NIH HHS/United States
U01 NS080818/NS/NINDS NIH HHS/United States
P01 AG019724/AG/NIA NIH HHS/United States
R25 NS098999/NS/NINDS NIH HHS/United States
U19 AG063911/AG/NIA NIH HHS/United States
R01 AG024040/AG/NIA NIH HHS/United States